Mary Lou Schmidt

Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma

David L. Baker, Mary Lou Schmidt, Susan L. Cohn et al. · New England Journal of Medicine · 2010 · 300 citations · Full text

Medicine, Cancer Biology, Oncology +13

Biologic Factors Determine Prognosis in Infants With Stage IV Neuroblastoma: A Prospective Children’s Cancer Group Study

Mary Lou Schmidt, John N. Lukens, Robert C. Seeger et al. · Journal of Clinical Oncology · 2000 · 240 citations

Medicine, Oncology, Pediatrics +13

Outcome After Surgery Alone or With Restricted Use of Chemotherapy for Patients With Low-Risk Neuroblastoma: Results of Children's Oncology Group Study P9641

Douglas Strother, Wendy B. London, Mary Lou Schmidt et al. · Journal of Clinical Oncology · 2012 · 239 citations

Medicine, Oncology, Surgery +7

Hearing Loss, Quality of Life, and Academic Problems in Long-term Neuroblastoma Survivors: A Report From the Children's Oncology Group

James G. Gurney, Jean M. Tersak, Kirsten K. Ness et al. · PEDIATRICS · 2007 · 198 citations

Medicine, Oncology, Pediatrics +13

A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants

Jed G. Nuchtern, Wendy B. London, Carol E. Barnewolt et al. · Annals of Surgery · 2012 · 196 citations · Full text

Medicine, Oncology, Surgery +16